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ABSTRACT: Mussel-inspired adhesive hydrogels represent
innovative candidate medical sealants or glues. In the present
work, we describe an enzyme-degradable mussel-inspired
adhesive hydrogel formulation, achieved by incorporating
minimal elastase substrate peptide Ala-Ala into the branched
poly(ethylene glycol) (PEG) macromonomer structure. The
system takes advantage of neutrophil elastase expression
upregulation and secretion from neutrophils upon recruitment
to wounded or inflamed tissue. By integrating adhesive
degradation behaviors that respond to cellular cues, we expand
the functional range of our mussel-inspired adhesive hydrogel platforms. Rapid (<1 min) and simultaneous gelation and adhesion
of the proteolytically active, catechol-terminated precursor macromonomer was achieved by addition of sodium periodate
oxidant. Rheological analysis and equilibrium swelling studies demonstrated that the hydrogel is appropriate for soft tissue-
contacting applications. Notably, hydrogel storage modulus (G′) achieved values on the order of 10 kPa, and strain at failure
exceeded 200% strain. Lap shear testing confirmed the material’s adhesive behavior (shear strength: 30.4 ± 3.39 kPa). Although
adhesive hydrogel degradation was not observed during short-term (27 h) in vitro treatment with neutrophil elastase, in vivo
degradation proceeded over several months following dorsal subcutaneous implantation in mice. This work represents the first
example of an enzymatically degradable mussel-inspired adhesive and expands the potential biomedical applications of this family
of materials.
■ INTRODUCTION
Present work in our laboratory seeks to address the challenge of
developing biocompatible adhesive hydrogel materials for soft-
tissue adhesion and repair. One approach takes inspiration from
mussel species such as Mytilus edulis: these bivalve mollusks
produce an adhesive holdfast called the byssus that mediates
attachment to heterogeneous organic and inorganic substrates
in the turbulent aquatic environment.
1,2 The byssus is
composed of fibrous threads which connect the internal byssal
retractor muscle to terminal adhesive plaques anchored to the
external substrate surface. Each byssal thread and adhesive
plaque is formed in an elegant injection molding process that
begins with secretion of liquid protein precursors into a cavity
defined by the mussel foot, followed rapidly by solidification of
the thread and plaque over several minutes. The process
concludes with disengagement of the mussel foot from the
newly formed thread and plaque, after which the entire process
is repeated numerous times to generate a full complement of
byssal threads. It has been demonstrated that byssal plaque
proteins mediate adhesive hardening and interfacial adhesion
and are enriched in 3,4-dihydroxyphenylalanine (DOPA), a
post-translationally modified amino acid.
3−5 The DOPA amino
acid side chain is catecholic, and under oxidizing conditions this
structure covalently cross-links both to itself and to biologically
relevant nucleophiles such as primary amines and thiols.
6−9
Incorporation of DOPA and DOPA-mimetic catechols into
hydrogel platforms has allowed us
10−12 and others
13−15 to
create candidate adhesive biomaterials with desirable physical
properties. Recently, we confirmed mussel-inspired adhesive
performance and tissue compatibility in both ex vivo and in
vivo model systems.
16,17 In an ex vivo analysis of adhesive
sealing of punctured human fetal membrane, our material
demonstrated minimal cellular toxicity, with excellent tissue
adhesion and integrity following applied radial strain.
16 We also
utilized mussel-inspired adhesive hydrogel for experimental islet
transplantation, employing the material as a sealant to
immobilize islets on tissue surfaces: the preservation of islet
viability and function yielded diabetes reversal in mice.
17 This
“islet sealant” application represented the first in vivo analysis of
a mussel-inspired adhesive and established the biocompatibility
and persistence of the material. In these studies, the adhesive
hydrogel material was composed of a branched poly(ethylene
glycol) (PEG) polymer functionalized with catechols through a
nondegradable linker. We now seek to expand the functional
applications of the mussel-inspired adhesive platform by
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desirable performance characteristics.
Modular design of catechol, linker, and polymer backbone
offers multiple opportunities to fine-tune adhesive hydrogel
material properties through architectural and compositional
changes to achieve specific goals such as mechanism and rate of
degradation. For example, peptidic substrate sequences may be
incorporated into the precursor backbone, thereby promoting
enzyme-directed hydrogel degradation behavior for cell- and
tissue-contacting applications. Indeed, proteolytically respon-
sive PEG hydrogels are well-documented in the literature for
tissue engineering,
18 regenerative medicine,
19 and molecular
delivery
20 applications as well as for the development of stem
cell niches.
21 In the context of adhesive hydrogel use for tissue
repair and reconstruction, it is appropriate to introduce
susceptibility to extracellular matrix proteases involved in
matrix restructuring and wound healing processes. Neutrophil
elastase is a serine protease secreted from activated neutrophils
in the context of their recruitment to a wound or site of local
inflammation. Addition of an elastase substrate peptide into the
polymer precursor structure thereby represents a means for
tailoring hydrogel degradation behaviors at these sites. As such,
incorporation of elastase-responsive behavior into PEG-based
hydrogels has been utilized for biomolecule delivery
22,23 and for
structural degradation in extracellular matrix-mimetic materi-
als.
24
Here we describe the design, in vitro characterization, and in
vivo performance of an elastase degradable mussel-inspired
adhesive hydrogel for soft tissue-contacting applications at sites
of injury or inflammation. A branched PEG reagent was
terminally modified with a DOPA-mimetic catechol linked to
the polymer backbone through an Ala-Ala dipeptide substrate
of elastase to generate an adhesive precursor macromonomer
(cAAPEG). Under oxidizing conditions, intermolecular cross-
linking of catechol groups drives rapid macromonomer
gelation, while catechol cross-linking to tissue surfaces
simultaneously imparts adhesive behavior. Rheological analysis,
equilibrium swelling studies, and lap shear testing confirmed
cAAPEG’s gelation and adhesive characteristics. Subcutaneous
implantation in mice revealed favorable tissue compatibility and
in vivo degradation of the material by cell-mediated elastase
activity.
■ EXPERIMENTAL SECTION
Materials and Animal Subjects. Amine-terminated four-arm
poly(ethylene glycol) (P4AM-10, MW 10 kDa) was purchased from
SunBio (Anyang City, South Korea). Fmoc-Ala-Ala-OH was
purchased from Bachem (Torrance, CA). Benzotriazol-1-yl-oxy-
tripyrrolidinophosphonium hexafluorophosphate (PyBOP) was pur-
chased from Novabiochem (EMD, Gibbstown, NJ). 3,4-Dihydroxyhy-
drocinnamic acid (DOHA), N,N-diisopropylethylamine (DIPEA),
triethylamine, and piperidine were purchased from Sigma (St. Louis,
MO). FITC-conjugated human sputum elastase was purchased from
Elastin Products Co. (Owensville, MO). Decellularized porcine dermis
extracellular matrix was generously supplied by Kensey Nash Corp.
(Exton, PA). Human neutrophil elastase (HNE) was purchased from
Innovative Research (Novi, MI). Mouse-reactive anti-rabbit neutrophil
elastase was purchased from Abcam, (Cambridge, MA), and the
EnVision+ system containing anti-rabbit secondary antibody con-
jugated to horseradish peroxidase-modified dextran polymer was
supplied by Dako (Carpinteria, CA).
Healthy, weight-matched male CD1 mice were purchased from
Charles River (Wilmington, MA). All animal studies were performed
under approval of the Northwestern Animal Care and Use Committee.
Synthesis and Characterization of Degradable cAAPEG
Macromonomer. 5.0 g of P4AM-10 was dissolved in 20 mL of
chloroform. 2.2945 g (6 mmol) of Fmoc-Ala-Ala-OH, 3.122 g (6
mmol) of PyBOP, and 2.090 mL (12 mmol) of DIPEA were added to
20 mL of dimethylformamide (DMF). These reagent solutions were
mixed and allowed to stir at room temperature for 3 h. The reaction
solution was precipitated overnight in cold anhydrous diethyl ether.
The resulting white precipitate was collected and dried overnight
under vacuum. The crude dried product (Fmoc-Ala-Ala-modified four-
arm PEG) was resuspended in 35 mL of methanol, and the resulting
yellow solution was precipitated overnight in cold anhydrous diethyl
ether. The secondary precipitate was collected and dried overnight
under vacuum. Dry product was resuspended in HCl-acidified water
(pH 5.2) and subjected to extensive dialysis (3500 MWCO) in HCl-
acidified water (pH 5.0−5.5). The aqueous dialyzed product was flash
frozen and lyophilized to yield the Fmoc-Ala-Ala-modified four-arm
PEG intermediate, and a negative Kaiser test indicated successful
modification.
Fmoc-Ala-Ala-modified four-arm PEG was reacted in 20%
piperidine in DMF for 2 h to remove the Fmoc protecting group,
after which the crude product was recovered by overnight precipitation
in cold anhydrous diethyl ether. The flocculent precipitate was
collected by centrifugation at 4 °C, dried, reconstituted in 35 mL of
methanol, and precipitated overnight in cold anhydrous diethyl ether.
The product (H2N-Ala-Ala-modified four-arm PEG) was isolated by
centrifugation at 4 °C and dried overnight under vacuum. A positive
Kaiser test indicated successful Fmoc deprotection.
4.0 g of H2N-Ala-Ala-modified four-arm PEG was dissolved in 20
mL of chloroform and combined with 0.7949 g (4.36 mmol) of
DOHA, 2.2704 g (4.36 mmol) of PyBOP, and 1.216 mL (8.72 mmol)
of triethylamine in 20 mL of DMF. The mixture was allowed to stir at
room temperature 2 h before overnight precipitation in cold
anhydrous diethyl ether. The resulting white precipitate was collected,
dried overnight under vacuum, resuspended in 12 mM HCl, and
subjected to extensive dialysis (3500 MWCO) in HCl-acidified water
(pH 3.5−4.0). The aqueous dialyzed product was filtered, flash frozen,
and lyophilized to yield the purified product (DOHA-Ala-Ala-modified
four-arm PEG; cAAPEG). A negative Kaiser test indicated complete
DOHA conjugation to terminal free amines of the H2N-Ala-Ala-
modified four-arm PEG intermediate.
Matrix-assisted laser desorption ionization (MALDI) mass spec-
trometry was performed on the four-arm amine-terminated PEG
reagent P4AM-10, synthetic intermediates, and the final product
cAAPEG macromonomer. Samples were analyzed in positive mode
using linear detection on an Autoflex III Smartbeam MALDI mass
spectrometer (Bruker Daltonics, Billerica, MA), using the flexControl
and flexAnalysis operational and processing software package.
cAAPEG macromonomer was dissolved in 12 mM HCl to a
concentration of 0.3 mg/mL, prior to UV−vis analysis (model U-
2010; Hitachi, San Jose, CA). Additionally, the 1H NMR spectrum of
cAAPEG macromonomer was obtained on an Inova 500 MHz
spectrometer (Varian, Palo Alto, CA) in deuterated chloroform at
room temperature.
All cAAPEG macromonomer utilized in enzymatic or tissue-
contacting studies was ethylene oxide gas sterilized on a 12 h cycle
prior to use (AN74i Anprolene sterilizer; Andersen Sterilizers, Haw
River, NC). Endotoxin analysis (BioTest Laboratories, Brooklyn Park,
MN) showed that undiluted cAAPEG macromonomer (14.5 mg in 40
mL of pyrogen-free water) contained less than 0.4 endotoxin units
(EU) in total sample, as measured by the Limulus Amebocyte Lysate
test.
Preparation of cAAPEG Hydrogels. cAAPEG macromonomer
was dissolved in 2× phosphate-buffered saline (PBS) pH 7.4 to a
concentration of 230 mg/mL (19.2 mM). Hydrogel formation was
induced by addition of an equal volume of 76.7 mM sodium periodate
in water. In all experiments excepting the gelation assay, homogeneous
mixing of the macromonomer solution and the sodium periodate
oxidizing solution was achieved by gel delivery from a dual-barrel
mixing tip device (Nordson Micromedics, St. Paul, MN). In the
gelation assay, solutions were briefly vortexed in a microcentrifuge
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occurred. For equilibrium swelling, in vitro hydrogel degradation, and
subcutaneous implantation studies, hydrogels were cast into PDMS
masks (diameter D = 20 mm, depth d = 2 mm; Sigma-Aldrich, St.
Louis, MO), and disk samples were generated from biopsy punch (D =
5 mm) of formed gel.
Rheological Characterization. Rheological analysis was per-
formed on a Paar Physica modular compact rheometer (MCR) 300,
with Peltier hood accessory for temperature and humidity control,
using US200/32 control software. Analysis of in situ gel formation was
carried out on mixtures of cAAPEG macromonomer and sodium
periodate delivered directly onto the rheometer plate fixture from the
dual-barrel mixing tip device described above. Changes in storage and
loss modulus corresponding to gel formation were monitored in
oscillatory mode using a 15 mm parallel plate with 1.0 mm gap, at 5%
strain and 10 rad/s with constant temperature (25 °C). Frequency
sweep was performed at 5% strain, 0.1 to 100 rad/s. Strain sweep was
performed at angular frequency 10 rad/s, 0.01% to 1000% strain, to gel
failure.
Equilibrium Swelling. cAAPEG hydrogel discs were weighed
immediately following formation (Wi) and swollen in sterile-filtered
deionized water at room temperature for 4 days. Water was changed
once per day. Samples were removed from water, blotted, and weighed
to obtain swollen mass (Ws). Gel swelling ratio was defined as follows:
Swollen samples were flash frozen and lyophilized to obtain gel
polymer dry mass (Wd).
Lap Shear Testing. The adhesive performance of cAAPEG
hydrogels was analyzed in a lap shear test adapted from ASTM
standard F2255-05 (reapproved 2010). Dry, decellularized porcine
dermis substrates were cut to 2.5 cm × 3 cm and rehydrated 1 h in
PBS. Dermal tissue substrates were immobilized on aluminum test
fixtures using cyanoacrylate glue, loosely covered with PBS-soaked
gauze, and allowed to cure for 1 h prior to adhesive hydrogel
deposition. cAAPEG adhesive hydrogel (100 μL) was applied to an
immobilized tissue substrate, and a second immobilized tissue
substrate was placed over the first, generating a single test sample.
Final dimensions of the area of substrate overlap and adhesive
interface were approximately 1.2 cm × 2.5 cm. PBS-soaked gauze was
placed over test samples (n = 4), and the cAAPEG adhesive was
allowed to cure at ambient conditions in air for 2 h. Immediately prior
to tensile testing, the area of substrate overlap was measured using
digital calipers. Samples were tested to failure in lap shear on an
Instron 5544 testing platform with Bluehill operating and analytical
software, at ambient conditions with 5 mm min−1 strain rate. Shear
strength was calculated from the measured maximum load and the
known area of adhesive overlap.
In Vitro Hydrogel Degradation. cAAPEG hydrogel disks were
swollen in sterile-filtered PBS + 0.3 mg/mL sodium azide at room
temperature for 4 days. The disks were incubated at 37 °C in PBS
containing 0.3 mg/mL sodium azide with (n = 4) or without (n = 4)
6.6 μM human neutrophil elastase (HNE). At predetermined time
points, samples were removed for weighing and immediately returned
to corresponding treatment solutions. At 0, 5, and 10 h of incubation,
and following termination of the experiment, HNE activity in
treatment solutions was assayed by monitoring evolution of
absorbance signal at 405 nm generated by neutrophil elastase-
mediated cleavage of commercially available chromogenic substrate
MeOSuc-Ala-Ala-Pro-Val-pNA (EMD Chemicals, Gibbstown, NJ) on
SpectraMax M5 plate reader with SoftPro Max analysis software.
Hydrogel Degradation Following Subcutaneous Implanta-
tion in Mice. All cAAPEG hydrogel casting, disk preparation, and
sample handling were performed under sterile conditions immediately
prior to animal surgery. Substrate-free cPEG hydrogels were prepared
as previously described;
17 implantable cAAPEG and cPEG disk
samples were otherwise handled identically. In advance of subcuta-
neous implantation, mice were anesthetized with nebulized isoflurane
(Isothesia, Butler Schein, Dublin, OH). Anesthesia was maintained
over the course of surgery by continuous isoflurane delivery through
nose cone. The dorsal surgical site was shaved, and the skin was
sterilized by alternating applications of betadine solution and 70%
ethanol and allowed to dry. A single, 1 cm incision was made at the
dorsal implantation site, and a subcutaneous pocket was created by no-
cut blunt dissection of the fascia between the dermis and the
underlying muscle tissue. A single cAAPEG or cPEG hydrogel disk
sample was implanted into the subcutaneous pocket prior to closure
with stainless steel wound clip. Mice were monitored until regaining
consciousness and recovery of normal grooming and feeding activities.
At 1, 3, 6, and 16 weeks postimplant, the hydrogel samples and
associated dermal, muscle, and fascia tissue were surgically removed
from anesthetized mice, prior to euthanasia. Samples were fixed
overnight in 10% neutral-buffered formalin at 4 °C and mounted in
paraffin. 4 μm tissue sections were subjected to hematoxylin and eosin
(HE) staining. Immunohistochemical identification of elastase was
achieved utilizing mouse-reactive antirabbit neutrophil elastase primary
antibody detected with the EnVision+ staining system utilizing anti-
rabbit secondary antibody conjugated to horseradish peroxidase-
modified dextran polymer.
Statistics. Data are presented as mean ± SEM, except where
indicated.
■ RESULTS AND DISCUSSION
Synthesis and Characterization of Degradable cAA-
PEG Macromonomer. To generate a rapidly forming and
mussel-inspired adhesive hydrogel material susceptible to
neutrophil elastase-mediated degradation, the cAAPEG macro-
monomer (Figure 1) was first prepared in three-step solution-
phase modification of a four-arm PEG reagent to yield a
branched precursor terminated with the cross-linkable, elastase
Figure 1. Oxidative cross-linking of enzymatically degradable cAAPEG macromonomer yields rapid and simultaneous gelation and tissue adhesion.
In the presence of neutrophil elastase, the Ala-Ala dipeptide linker (blue) is cleaved to provide cell-mediated structural degradation. Black
arrowheads indicate continuation of the cross-linked hydrogel matrix.
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ate-mediated cross-linking of oxidized DOHA catechol is
responsible for hydrogel network formation, selection of the
putative elastase substrate was not trivial, as nucleophile-
presenting peptide sequences must be assiduously avoided.
Otherwise, the competitive chemical cross-linking of highly
reactive, oxidized catechol moieties such o-quinone to
nucleophilic amino acid(s) would render the substrate
nonresponsive to elastase activity. Another important element
of elastase substrate design involved minimizing substrate
length. Although longer peptides are generally better substrates
and are predicted to promote more rapid degradation, minimal
substrates enjoy many benefits such as simplified synthesis,
lower cost, and reduced immunogenicity. Taking these
parameters into consideration, as well as the preference of
elastase for small, hydrophobic amino acids at the site of
enzymatic cleavage,
25 the dipeptide Ala-Ala was selected as the
elastase substrate in this degradable hydrogel formulation.
Notably, elastase-mediated cleavage at an Ala-Ala sequence has
been previously demonstrated in peptide−lipid conjugates
26
and utilized for molecular payload delivery from hydrogel
27 and
mesoporous silica particles.
28
The cAAPEG macromonomer was synthesized without
complication on the multigram scale with relatively high yield
(∼80%), facilitating extensive in vitro and in vivo analysis of the
material. The purified, lyophilized, off-white cAAPEG powder
demonstrated excellent shelf life and dissolved easily in aqueous
and organic solvents to yield a solution with faint yellow tint.
Solutions of the macromonomer in water and neutral pH buffer
darkened over several days, suggesting oxidative mechanisms.
For this reason, all solutions containing macromonomer were
freshly prepared, immediately prior to use.
The cAAPEG macromonomer was characterized by MALDI
mass spectrometry, UV−vis spectrophotometry, and 1H NMR.
MALDI mass spectrometry data of branched P4AM-10 reagent,
synthetic intermediates, and cAAPEG macromonomer con-
firmed successful preparation of cAAPEG macromonomer
(Figure 2a). In this figure, spectrum 2 (Fmoc-Ala-Ala four-arm
PEG) demonstrated a clear increase in molecular weight from
the PEG reagent (spectrum 1), and the subsequent Fmoc
deprotection step generated an obvious shift to lower molecular
Figure 2. Characterization of the cAAPEG macromonomer. Matrix-assisted laser deionization (MALDI) mass spectrometry (a) confirmed the
changes in molecular mass expected during stepwise synthesis of cAAPEG macromonomer (∼12 kDa). UV−vis spectrophotometry of cAAPEG
macromonomer (b) revealed a peak at 280 nm corresponding to catechol, with little evidence of oxidized species (>300 nm). Structural confirmation
of cAAPEG macromonomer by 1H NMR (c) was performed in deuterated chloroform; peak assignments corresponding to PEG backbone, Ala-Ala
linker, and catechol protons are indicated in italics.
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terminal DOHA addition increased cAAPEG product peak
molecular weight to the predicted value of ∼12 kDa (spectrum
4). UV−vis spectrophotometric analysis of cAAPEG macro-
monomer showed an absorbance maximum of the dihydrox-
ybenzyl (catechol) moiety at 280 nm, with minimal
contribution from undesirable oxidized components at 320
nm and higher wavelengths
29 (Figure 2b), demonstrating that
terminal catechol groups were unoxidized at completion of
cAAPEG macromonomer synthesis. Interpolation of macro-
monomer absorbance at 280 nm against a standard curve of
known catechol concentration confirmed quantitative cAAPEG
terminal modification by DOHA (0.762 μmol of catechol per
mg of polymer, Supporting Information Figure S1). NMR
analysis of cAAPEG macromonomer identified the protons
contributed by the PEG polymer backbone, the Ala-Ala
dipeptide linker, and the terminal catechol of DOHA. As
shown in Figure 2c, signals d, d′ and e, e′ associated with the
Ala-Ala dipeptide are observed at 4.4 and 0.6 ppm, respectively,
while DOHA-associated methylenic signals b and c and
aromatic hydrogens (a) are clearly present. A strong signal
from ether hydrogens of the PEG backbone (f) is centered near
3.6 ppm.
Physical Characterization of cAAPEG Adhesive Hydro-
gels. Neutrophil elastase-degradable cAAPEG was designed as
an enzyme-reactive hydrogel to expand the functional range
and potential applications of mussel-inspired adhesive materials.
Catechol end groups of the cAAPEG macromonomer allow for
rapid and oxidation-mediated cross-linking upon mixing with
periodate.
29 Immediately upon mixing cAAPEG macromono-
mer and sodium periodate solutions, a transition from colorless
to medium brown was observed, followed rapidly by gel
formation within 20−30 s. As cAAPEG is a candidate soft-tissue
adhesive or sealant material, this color change represents a
desirable performance characteristic: upon in situ delivery, the
location of adhesive deposition would be visible. This evolution
is related to periodate-induced catechol oxidation to highly
reactive groups such as o-quinone, with corresponding
absorbance shifts into visible wavelengths. Chemical cross-
linking of these reactive groups is responsible for macro-
monomer intermolecular cross-linking and hydrogel forma-
tion.
29 It is notable that introduction of the Ala-Ala dipeptide
substrate between terminal catechol groups and the PEG core
did not significantly impact cAAPEG gelation behavior when
compared to peptide linker-free catechol-modified cPEG
adhesive hydrogel.
17
In situ rheological analysis of cAAPEG hydrogels confirmed
rapid formation of an elastic gel upon mixing with periodate.
Because of rapid gelation kinetics (<1 min), it was not possible
to observe G′/G″ crossover (Figure 3a), a commonly employed
indicator of gelation.
30 Nevertheless, storage modulus G′
rapidly increased 1−2 min after mixing cAAPEG macro-
monomer and periodate solutions, before achieving plateau
values on the order of 10 kPa. This value conforms with
rheological analyses of other enzymatically degradable branched
PEG hydrogels
31 and underlines the material’s potential utility
in soft tissue-contacting applications. Comparatively low loss
modulus G″ indicated solidlike behavior of the cAAPEG
adhesive hydrogel. Gel stability was demonstrated in frequency
sweep analysis, which verified that storage and loss moduli were
independent of applied angular frequency (Figure 3b). Strain
sweep analysis showed strain at failure (secondary G′/G″
crossover) above 200% strain, illustrating the mechanical
robustness of the hydrogel (Figure 3c).
In a complementary set of studies, equilibrium swelling and
macromolecular infiltration into the cAAPEG hydrogel network
were assessed. Equilibrium swelling analysis indicated a
cAAPEG swelling ratio of 34.3% (>90% water), suggesting a
well-cross-linked network with robust mechanical strength.
Confocal microscopy of hydrogels immersed in buffer
containing fluorescently tagged elastase (∼30 kDa) revealed
homogeneous fluorescence signal, confirming the ability of
elastase enzyme to uniformly infiltrate the cross-linked network
within 12 h (Supporting Information, Figure S2). Cross-linked
Figure 3. Rheological characterization of cAAPEG adhesive hydrogel
formation (a), frequency sweep (b), and strain sweep (c) analyses.
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infiltration behavior.
22
In addition to characterization of cross-linked cAAPEG as a
hydrogel material, lap shear testing established its potential for
tissue adhesion. cAAPEG hydrogel was applied to porcine
dermal tissue substrates attached to aluminum tags and allowed
to cure for a short period (2 h) prior to tensile testing. These
experimental conditions best approximate early postapplication
performance, in contrast to the 12−24 h cure times utilized in
other studies. The mean shear strength of the adhesive was 30.4
± 3.39 kPa. Although it is difficult to directly compare this
result with other studies due to differences in methodology and
tissue types, this value is similar to those obtained from PEG-
based adhesives developed in our group
12 and elsewhere
32 and
is several times greater than fibrin glue shear strength
measurements obtained in those studies (<10 kPa). In all
tests the bonded samples underwent cohesive failure (Figure
4), indicating excellent adhesion of the cAAPEG hydrogel to
the tissue. Similar performance is anticipated for in situ
cAAPEG adhesion to living biological tissues.
cAAPEG Adhesive Hydrogel Degradation Analysis.
Cross-linked cAAPEG hydrogels presenting Ala-Ala dipeptide
were designed to degrade in the presence of the proteolytic
enzyme neutrophil elastase. The in vitro response of cAAPEG
hydrogels to elastase proteolytic activity was assessed over a 27
h period. Samples were exposed to neutrophil elastase-
containing buffer solutions at the outset of the experiment,
and no repeat dosing was performed. Enzyme activity assays
confirmed that human neutrophil elastase (HNE) activity
decreased with time: the protease lost ∼90% of its initial
activity over the course of the experiment performed at 37 °C
(Supporting Information, Figure S3a). This study was designed
to assess very short-term response to a single enzyme
treatment. Under these stringent treatment conditions, HNE-
mediated cAAPEG hydrogel degradation was not detected by
mass loss measurements (Supporting Information, Figure S3b).
In contrast, it has previously been shown that thiol−ene
photopolymerized PEG hydrogels with elastase-sensitive 12-
mer peptide cross-links degraded in a matter of hours in an
enzyme concentration-dependent fashion.
23 It is important to
consider that the minimal Ala-Ala dipeptide utilized in the
present study was predicted to be a relatively inefficient elastase
substrate, selected to permit material degradation over longer
periods. This explains the lack of mass loss observed in
stringent, short-term in vitro analysis.
Based on the finding that neutrophil elastase-mediated
degradation of cAAPEG hydrogels likely occurs over a time
period poorly suited to in vitro assessment, cAAPEG hydrogel
implantation was performed to characterize material degrada-
tion over an extended period in vivo. This approach
furthermore represented a more realistic assessment of its
performance, as an in vitro platform cannot fully reconstitute
the complex chemical environment present in an intact, living
tissue. cAAPEG hydrogel samples were implanted subcuta-
neously in mice as preformed 5 mm disks and subsequently
removed at specified time points for histological and
immunohistochemical analysis. Hydrogel disks exhibited good
integration with surrounding tissues at the time of explant
surgery. At 1 week postimplantation, there was evidence of
cellular infiltration into the hydrogel (Figure 5a,b), and
immunohistochemical staining for elastase was positive at the
cAAPEG−tissue interface, suggesting the presence of elastase
secreted by activated neutrophils (Figure 5b and inset). At
subsequent explant time points, the degree of cellular
infiltration and hydrogel surface erosion demonstrably
increased with time. In hydrogel samples removed 3 weeks
following implantation, significant cellular infiltration and gel
restructuring corresponded with dramatic elastase staining at
the interface of the infiltrating cell population and the cAAPEG
surface (Figure 5c,d). At 6 weeks following implantation,
distinctive hydrogel surface irregularities were associated with
cellular infiltration several hundreds of micrometers into the
bulk hydrogel network (Figure 5e,f). Surface irregularities were
also present at the 16 week time point, and histological
processing of these explanted samples suggested that hydrogel
restructuring by infiltrating cells is followed by fibrous matrix
deposition at extended time points, similar to the outcome of
wound healing (Figure 5g). Notably, positive elastase staining
and cellular infiltration were observed within the bulk cAAPEG
hydrogel, made more evident with slight sample separation that
occurred as an artifact of processing (Figure 5h and inset).
The impact of incorporating elastase-responsive Ala-Ala
dipeptide substrate into the macromolecular cAAPEG hydrogel
network was underlined by contrasting its degradation behavior
to that of substrate-free cPEG hydrogel. Facile addition of the
minimal elastase substrate dramatically altered this behavior,
converting an inert implantable adhesive (cPEG; Figure 6a)
into a material undergoing extensive cell-mediated degradation
at 16 weeks, across the millimeter scale (cAAPEG; Figure 6b).
In these sagittal sections, implanted cPEG maintained distinct
linear surfaces, whereas ongoing cAAPEG degradation led to
significant cellular infiltration, surface roughness, and disruption
of original sample geometry. Following implantation at the
dorsal subcutaneous site, cAAPEG degrades via enzyme-
mediated surface erosion, preferentially from the underside
and edges of the sample. This finding was consistent within
cAAPEG groups and at each time point assessed. In contrast,
cPEG demonstrated no cellular infiltration and no degradation,
in agreement with our previous in vivo studies.
17
cAAPEG adhesive hydrogel was designed to degrade in a
wounded or inflamed tissue environment through the
enzymatic activity of elastase secreted from activated
neutrophils. Histological and immunohistochemical analysis
Figure 4. Photograph of decellularized porcine dermis bonded with
cAAPEG adhesive hydrogel and then fractured under lap shear after 2
h. Cohesive failure is indicated by the presence of cAAPEG adhesive
hydrogel (dark) on both fracture surfaces.
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over a period of several months in vivo. In explanted hydrogel
samples, evidence of elastase expression at the cAAPEG−tissue
interface suggested that this material experienced structural
degradation mediated, at least in part, by this enzyme. In this
set of experiments, tissue infiltration by activated neutrophils
represented a nonspecific inflammatory response to dermal
incision and subcutaneous implantation of cAAPEG hydrogel
samples. cAAPEG was not designed to initiate a chronic
inflammatory response; therefore, elastase expression by
activated neutrophils appeared to decrease over time. However,
this outcome should not prohibit further cAAPEG degradation
at extended time points: given that the Ala-Ala dipeptide is a
minimal substrate, it is likely that other ECM-resident proteases
such as matrix metalloproteinases (MMPs) participated in
cAAPEG hydrogel degradation in vivo, as suggested for other
PEG-based hydrogels incorporating minimal substrates for
degradation by plasmin.
33 In the present work it is expected
that longer neutrophil elastase substrate peptide sequences
would shorten the timeline of in vivo hydrogel degradation,
while increasing the risk of antigen-specific immunogenicity of
the material.
■ CONCLUSIONS
We have developed an adhesive hydrogel inspired by marine
mussel holdfasts and engineered to degrade by the proteolytic
Figure 5. Histological (a, c, e, g) and immunohistochemical (b, d, f, h) analysis of subcutaneously implanted cAAPEG confirmed in vivo neutrophil
elastase-mediated degradation of this material. Scale bars: 200 μm, all images. White arrows: site of cellular infiltration into the cAAPEG adhesive
hydrogel. Black arrows: positive neutrophil elastase stain.
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conditions, cAAPEG gelation and adhesion to tissue occurred
in less than 1 min. Rheological analysis, equilibrium swelling
studies, and lap shear testing elucidated the material’s hydrogel
and adhesive properties. Adhesive hydrogels presenting
minimal Ala-Ala dipeptide linker for neutrophil elastase-
mediated degradation were not found to degrade during
short-term in vitro analysis; however, in vivo subcutaneous
implantation studies in mice confirmed that this material slowly
degraded and elicited a minimal inflammatory tissue response.
cAAPEG is the first example of an enzyme-degradable mussel-
inspired adhesive, and this material demonstrated attractive
properties for use immediately following soft-tissue injury, for
applications in nonstatic tissues including the gut and the
vasculature, and for adhesion in a chronically inflamed
environment such as hernia. Other recently introduced
candidate medical adhesives have similarly focused on tissue-
specific applications, including wound care for diabetic ulcers,
34
suture adjunct for corneal tissue,
35 and surgical repair of
peripheral nerves.
36 As such, future experiments will interrogate
the performance and degradation of in situ-formed adhesive in
a wound healing or chronic inflammation model.
■ ASSOCIATED CONTENT
* S Supporting Information
Standard curve of the catechol end group concentration assay;
confocal fluorescence microscopy of cAAPEG adhesive hydro-
gel infiltration by FITC-elastase; elastase enzymatic activity
assays; raw sample mass data from in vitro elastase degradation
of adhesive hydrogel. This material is available free of charge via
the Internet at http://pubs.acs.org.
■ AUTHOR INFORMATION
Corresponding Author
*Tel: +1 847 467 5273. Fax: +1 847 491 4928. E-mail: philm@
northwestern.edu.
■ ACKNOWLEDGMENTS
We thank Nicholas Talarico and Bella Shmaltsuyev of the
Pathology Core Facility, and Donna Emge of the Mouse
Histology and Phenotyping Laboratory, Robert H. Lurie
Comprehensive Cancer Center of Northwestern University,
for assistance with histology and immunohistochemistry. The
authors thank Kensey Nash Corporation for their generous
donation of decellularized porcine dermis. This work was
supported by National Institutes of Health Grants R01
DE021215, R01 DE021104, and R37 DE014193.
■ REFERENCES
(1) Waite, J. H. Integr. Comp. Biol. 2002, 42, 1172−1180.
(2) Lee, B. P.; Messersmith, P. B.; Israelachvili, J. N.; Waite, J. H.
Annu. Rev. Mater. Res. 2011, 41, 99−132.
(3) Waite, J. H.; Tanzer, M. L. Science 1981, 212, 1038−1040.
(4) Papov, V. V.; Diamond, T. V.; Biemann, K.; Waite, J. H. J. Biol.
Chem. 1995, 270, 20183−20192.
(5) Waite, J. H.; Qin, X. Biochemistry 2001, 40, 2887−2893.
(6) Yu, M. E.; Hwang, J. Y.; Deming, T. J. J. Am. Chem. Soc. 1999,
121, 5825−5826.
(7) Burzio, L. A.; Waite, J. H. Biochemistry 2000, 39, 11147−11153.
(8) Lee, H.; Scherer, N. F.; Messersmith, P. B. Proc. Natl. Acad. Sci. U.
S. A. 2006, 103, 12999−13003.
(9) Zhao, H.; Waite, J. H. J. Biol. Chem. 2006, 281, 26150−26158.
(10) Huang, K.; Lee, B. P.; Ingram, D. R.; Messersmith, P. B.
Biomacromolecules 2002, 3, 397−406.
(11) Catron, N. D.; Lee, H.; Messersmith, P. B. Biointerphases 2006,
1, 134−141.
(12) Burke, S. A.; Ritter-Jones, M.; Lee, B. P.; Messersmith, P. B.
Biomed. Mater. 2007, 2, 203−210.
(13) Westwood, G.; Horton, T. N.; Wilker, J. J. Macromolecules 2007,
40, 3960−3964.
(14) Shazly, T. M.; Baker, A. B.; Naber, J. R.; Bon, A.; Van Vliet, K. J.;
Edelman, E. R. J. Biomed. Mater. Res. A 2010, 95, 1159−1169.
(15) Lee, Y.; Chung, H. J.; Yeo, S.; Ahn, C. H.; Lee, H.; Messersmith,
P. B.; Park, T. G. Soft Matter 2010, 6, 977−983.
(16) Bilic, G.; Brubaker, C.; Messersmith, P. B.; Mallik, A. S.; Quinn,
T. M.; Haller, C.; Done, E.; Gucciardo, L.; Zeisberger, S. M.;
Zimmermann, R.; Deprest, J.; Zisch, A. H. Am. J. Obstet. Gynecol. 2010,
202 (85), e81−89.
(17) Brubaker, C. E.; Kissler, H.; Wang, L. J.; Kaufman, D. B.;
Messersmith, P. B. Biomaterials 2010, 31, 420−427.
(18) Zhu, J. Biomaterials 2010, 31, 4639−4656.
(19) Lutolf, M. P.; Lauer-Fields, J. L.; Schmoekel, H. G.; Metters, A.
T.; Weber, F. E.; Fields, G. B.; Hubbell, J. A. Proc. Natl. Acad. Sci. U. S.
A. 2003, 100, 5413−5418.
(20) Lin, C. C.; Anseth, K. S. Pharm. Res. 2009, 26, 631−643.
(21) Li, Y. J.; Chung, E. H.; Rodriguez, R. T.; Firpo, M. T.; Healy, K.
E. J. Biomed. Mater. Res., Part A 2006, 79A, 1−5.
(22) Aimetti, A. A.; Tibbitt, M. W.; Anseth, K. S. Biomacromolecules
2009, 10, 1484−1489.
(23) Aimetti, A. A.; Machen, A. J.; Anseth, K. S. Biomaterials 2009,
30, 6048−6054.
(24) Mann, B. K.; Gobin, A. S.; Tsai, A. T.; Schmedlen, R. H.; West,
J. L. Biomaterials 2001, 22, 3045−3051.
(25) Sweeney, P. J.; Walker, J. M. In Methods in Molecular Biology;
Burrell, M. M., Ed.; Humana Press: Totowa, NJ, 1993; Vol. 16, pp
277−303.
(26) Pak, C. C.; Ali, S.; Janoff, A. S.; Meers, P. Biochim. Biophys. Acta
1998, 1372, 13−27.
Figure 6. Histological analysis of subcutaneously implanted substrate-free cPEG (a) and elastase-responsive cAAPEG (b) mussel-inspired adhesive
hydrogels highlighted the role of the Ala-Ala dipeptide substrate in cAAPEG degradation at 16 weeks following implantation. Scale bars: 500 μm,
both images.
Biomacromolecules Article
dx.doi.org/10.1021/bm201261d | Biomacromolecules 2011, 12, 4326−4334 4333(27) Thornton, P. D.; Mart, R. J.; Webb, S. J.; Ulijn, R. V. Soft Matter
2008, 4, 821−827.
(28) Thornton, P. D.; Heise, A. J. Am. Chem. Soc. 2010, 132, 2024−
2028.
(29) Lee, B. P.; Dalsin, J. L.; Messersmith, P. B. Biomacromolecules
2002, 3, 1038−1047.
(30) Ross-Murphy, S. B. Polym. Gels Networks 1994, 2, 229−237.
(31) van Dijk, M.; van Nostrum, C. F.; Rijkers, D. T. S.; Liskamp, R.
M. J.; Hennink, W. E. Biomacromolecules 2010, 11, 1608−1614.
(32) Strehin, I.; Nahas, Z.; Arora, K.; Nguyen, T.; Elisseeff, J.
Biomaterials 2010, 31, 2788−2797.
(33) Jo, Y. S.; Rizzi, S. C.; Ehrbar, M.; Weber, F. E.; Hubbell, J. A.;
Lutolf, M. P. J. Biomed. Mater. Res., Part A 2010, 93, 870−877.
(34) Choi, J. S.; Yoo, H. S. J. Biomed. Mater. Res., Part A 2010, 95A,
564−573.
(35) Oelker, A. M.; Berlin, J. A.; Wathier, M.; Grinstaff, M. W.
Biomacromolecules 2011, 12, 1658−1665.
(36) Rickett, T. A.; Amoozgar, Z.; Tuchek, C. A.; Park, J.; Yeo, Y.;
Shi, R. Y. Biomacromolecules 2011, 12, 57−65.
Biomacromolecules Article
dx.doi.org/10.1021/bm201261d | Biomacromolecules 2011, 12, 4326−4334 4334